Cancers | Free Full-Text | Targeting BCL-2 in Cancer: Advances, Challenges, and Perspectives
Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin | PLOS ONE
Frontiers | The Multifaceted Roles of the BCL-2 Family Member BOK
Expression of Bcl-2 protein is decreased in colorectal adenocarcinomas with microsatellite instability | Oncogene
Phosphorylation of Bcl-2 plays an important role in glycochenodeoxycholate-induced survival and chemoresistance in HCC
Emerging understanding of Bcl-2 biology: Implications for neoplastic progression and treatment - ScienceDirect
Bcl-2 as a clinical prognostic marker. | Download Table
IJMS | Free Full-Text | Co-Operativity between MYC and BCL-2 Pro-Survival Proteins in Cancer | HTML
PDF) ANALYSIS OF ANTIAPOPTOTIC PROTEIN BCL2 BY IMMUNOHISTOCHEMISTRY AND ITS CORRELATION WITH THE PROGNOSIS IN PATIENT WITH COLORECTAL CANCER
Quantitative analysis of tumor-specific BCL2 expression in DLBCL: refinement of prognostic relevance of BCL2 | Scientific Reports
Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settings - Annals of Oncology
Cancers | Free Full-Text | BCL-2 Proteins in Pathogenesis and Therapy of B-Cell Non-Hodgkin Lymphomas
Bax expression is a candidate prognostic and predictive marker of colorectal cancer - Katkoori - Journal of Gastrointestinal Oncology
Bcl-2 as a clinical prognostic marker. | Download Table
MYC, BCL2, and BCL6 expression as prognostic indicators in primary central nervous system lymphoma: A systematic review and meta-analysis - ScienceDirect
BCL-XL is crucial for progression through the adenoma-to-carcinoma sequence of colorectal cancer | Cell Death & Differentiation
YAP inhibits autophagy and promotes progression of colorectal cancer via upregulating Bcl-2 expression | Cell Death & Disease
BCL-2 family deregulation in colorectal cancer: potential for BH3 mimetics in therapy | SpringerLink
Colorectal Cancer Screening Methods and Molecular Markers for Early Detection - Ziwei Wu, You Li, Yibin Zhang, Hui Hu, Tangwei Wu, Shuiyi Liu, Weiqun Chen, Shenggao Xie, Zhongxin Lu, 2020
Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine | Modern Pathology
Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer | Cell Death & Disease
![PDF] Is Bax/Bcl-2 Ratio Considered as a Prognostic Marker with Age and Tumor Location in Colorectal Cancer? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/423098cc326d4983e1c46704685fa877fa0ac94e/5-Figure2-1.png "PDF] Is Bax/Bcl-2 Ratio Considered as a Prognostic Marker with Age and Tumor Location in Colorectal Cancer? | Semantic Scholar")
PDF] Is Bax/Bcl-2 Ratio Considered as a Prognostic Marker with Age and Tumor Location in Colorectal Cancer? | Semantic Scholar
PDF) Is Bax/Bcl-2 Ratio Considered as a Prognostic Marker with Age and Tumor Location in Colorectal Cancer?
ORIGINAL RESEARCH PAPER Dr.Aruna kumara pagalla* Dr.Prashanth Gunde Dr.Aruna
